InvestorsHub Logo
Followers 15
Posts 524
Boards Moderated 0
Alias Born 12/28/2009

Re: Tiger Money post# 38438

Friday, 04/16/2021 11:59:14 PM

Friday, April 16, 2021 11:59:14 PM

Post# of 44690
IMO it would be a big mistake to sell RLFTF now.
Relief Therapeutics are not lazy Europeans. But they wont be fooled, if others try to buy their patent piece by piece. The cooperation with AdVita is now so successful that they care about the result of the clinical evaluation of their new study only and it doesn't matter whether NeuroRx is successful in case of EUA or not.
Relief originally funded the NeuroRx costs, but now it's game over. It is now up to Big Rock Partners whether they continue to show interest in Zyesami.